Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Allison

Showing results (121-130 of 206) with videos related to

Pageof 21
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivationAnja C Roden, Michael T Moser, Samuel D Tri, et al.
Cancer Immunology Research|August 31, 2019
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated MannerLewis Zhichang Shi, Sangeeta Goswami, Tihui Fu, et al.
Nature Medicine|August 4, 2015
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosisSara Lovisa, Valerie S LeBleu, Björn Tampe, et al.
Cytotherapy|November 12, 2009
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responsesYun Lin, Humilidad F Gallardo, Geoffrey Y Ku, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Nature Immunology|June 11, 2003
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Norihiko Watanabe, Maya Gavrieli, John R Sedy, et al.
Cancer Immunology Research|June 6, 2024
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote TumorigenesisSusana Castro-Pando, Rian M Howell, Le Li, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
The Journal of Experimental Medicine|July 31, 2013
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanomaTyler R Simpson, Fubin Li, Welby Montalvo-Ortiz, et al.
Pageof 21

Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivationAnja C Roden, Michael T Moser, Samuel D Tri, et al.
Cancer Immunology Research|August 31, 2019
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated MannerLewis Zhichang Shi, Sangeeta Goswami, Tihui Fu, et al.
Nature Medicine|August 4, 2015
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosisSara Lovisa, Valerie S LeBleu, Björn Tampe, et al.
Cytotherapy|November 12, 2009
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responsesYun Lin, Humilidad F Gallardo, Geoffrey Y Ku, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Nature Immunology|June 11, 2003
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Norihiko Watanabe, Maya Gavrieli, John R Sedy, et al.
Cancer Immunology Research|June 6, 2024
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote TumorigenesisSusana Castro-Pando, Rian M Howell, Le Li, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
The Journal of Experimental Medicine|July 31, 2013
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanomaTyler R Simpson, Fubin Li, Welby Montalvo-Ortiz, et al.
Pageof 21